Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Titel:
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Auteur:
Bruce, Ian N Nami, Alireza Schwetje, Erik Pierson, M Edward Rouse, Tomas Chia, Yen Lin Kuruvilla, Denison Abreu, Gabriel Tummala, Raj Lindholm, Catharina